tiprankstipranks
XOMA Royalty Corporation (DE:X0M1)
MUNICH:X0M1
Germany Market
X0M1
XOMA Royalty Corporation
RESEARCH TOOLSreports

XOMA Royalty Corporation (X0M1) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

X0M1 Analyst Ratings

Hold
3Ratings
Hold
0 Buy
3 Hold
0 Sell
Based on 3 analysts giving stock ratings to
XOMA
Royalty Corporation
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

X0M1 Stock 12 Month Forecast

Average Price Target

€34.24
▲(3.76% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for XOMA Royalty Corporation in the last 3 months. The average price target is €34.24 with a high forecast of €34.24 and a low forecast of €34.24. The average price target represents a 3.76% change from the last price of €33.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"19":"€19","38":"€38","23.75":"€23.8","28.5":"€28.5","33.25":"€33.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":34.24122312,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€34.24</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":34.24122312,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€34.24</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":34.24122312,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€34.24</span>\n  </div></div>","useHTML":true}}],"tickPositions":[19,23.75,28.5,33.25,38],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37,36.787786393846154,36.57557278769231,36.36335918153846,36.15114557538462,35.93893196923077,35.72671836307693,35.514504756923074,35.30229115076923,35.09007754461538,34.87786393846154,34.66565033230769,34.453436726153846,{"y":34.24122312,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37,36.787786393846154,36.57557278769231,36.36335918153846,36.15114557538462,35.93893196923077,35.72671836307693,35.514504756923074,35.30229115076923,35.09007754461538,34.87786393846154,34.66565033230769,34.453436726153846,{"y":34.24122312,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37,36.787786393846154,36.57557278769231,36.36335918153846,36.15114557538462,35.93893196923077,35.72671836307693,35.514504756923074,35.30229115076923,35.09007754461538,34.87786393846154,34.66565033230769,34.453436726153846,{"y":34.24122312,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":20.6,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.6,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.2,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.8,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.2,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.4,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.8,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.2,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.6,"date":1780272000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":37,"date":1782864000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€34.24Average Price Target€34.24Lowest Price Target€34.24
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Benchmark Co. Analyst forecast on DE:X0M1
Robert Wasserman
Benchmark Co.
Benchmark Co.
―
Hold
―
Downgraded
05/22/26
Xoma downgraded to Hold from Buy at BenchmarkXoma downgraded to Hold from Buy at Benchmark
H.C. Wainwright Analyst forecast on DE:X0M1
Joseph Pantginis
H.C. Wainwright
H.C. Wainwright
€85.16→€34.24
Hold
3.76%
Upside
Downgraded
04/30/26
Xoma downgraded to Neutral from Buy at H.C. WainwrightXoma downgraded to Neutral from Buy at H.C. Wainwright
Lucid Capital Analyst forecast on DE:X0M1
Elemer Piros
Lucid Capital
Lucid Capital
€57.95→€34.24
Hold
3.76%
Upside
Downgraded
04/27/26
Xoma downgraded to Neutral from Buy at Lucid CapitalXoma downgraded to Neutral from Buy at Lucid Capital
TD Cowen Analyst forecast on DE:X0M1
Phil Nadeau
TD Cowen
TD Cowen
―
Hold
―
Reiterated
03/18/26
Analysts Offer Insights on Healthcare Companies: XOMA Royalty Corporation (NASDAQ: XOMA) and HCW Biologics (NASDAQ: HCWB)
Leerink Partners Analyst forecast on DE:X0M1
David Risinger
Leerink Partners
Leerink Partners
€39.51→€43.9
Buy
33.03%
Upside
Reiterated
02/24/26
Xoma price target raised to $50 from $45 at LeerinkXoma price target raised to $50 from $45 at Leerink
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Benchmark Co. Analyst forecast on DE:X0M1
Robert Wasserman
Benchmark Co.
Benchmark Co.
―
Hold
―
Downgraded
05/22/26
Xoma downgraded to Hold from Buy at BenchmarkXoma downgraded to Hold from Buy at Benchmark
H.C. Wainwright Analyst forecast on DE:X0M1
Joseph Pantginis
H.C. Wainwright
H.C. Wainwright
€85.16→€34.24
Hold
3.76%
Upside
Downgraded
04/30/26
Xoma downgraded to Neutral from Buy at H.C. WainwrightXoma downgraded to Neutral from Buy at H.C. Wainwright
Lucid Capital Analyst forecast on DE:X0M1
Elemer Piros
Lucid Capital
Lucid Capital
€57.95→€34.24
Hold
3.76%
Upside
Downgraded
04/27/26
Xoma downgraded to Neutral from Buy at Lucid CapitalXoma downgraded to Neutral from Buy at Lucid Capital
TD Cowen Analyst forecast on DE:X0M1
Phil Nadeau
TD Cowen
TD Cowen
―
Hold
―
Reiterated
03/18/26
Analysts Offer Insights on Healthcare Companies: XOMA Royalty Corporation (NASDAQ: XOMA) and HCW Biologics (NASDAQ: HCWB)
Leerink Partners Analyst forecast on DE:X0M1
David Risinger
Leerink Partners
Leerink Partners
€39.51→€43.9
Buy
33.03%
Upside
Reiterated
02/24/26
Xoma price target raised to $50 from $45 at LeerinkXoma price target raised to $50 from $45 at Leerink
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TARAProtara Therapeutics
BKDBrookdale Senior Living
EYPTEyePoint Pharmaceuticals
ZVRAZevra Therapeutics
DFTXDefinium Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering XOMA Royalty Corporation

3 Months
David RisingerLeerink Partners
Success Rate
8/13 ratings generated profit
62%
Average Return
+8.52%
Copying David Risinger's trades and holding each position for 3 Months would result in 61.54% of your transactions generating a profit, with an average return of +8.52% per trade.
1 Year
David RisingerLeerink Partners
Success Rate
11/13 ratings generated profit
85%
Average Return
+31.35%
Copying David Risinger's trades and holding each position for 1 Year would result in 84.62% of your transactions generating a profit, with an average return of +31.35% per trade.
2 Years
David RisingerLeerink Partners
Success Rate
13/13 ratings generated profit
100%
Average Return
+64.76%
Copying David Risinger's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +64.76% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

X0M1 Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
2
2
1
0
0
Buy
0
0
0
0
0
Hold
2
4
4
3
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
6
5
3
1
In the current month, X0M1 has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. X0M1 average Analyst price target in the past 3 months is 34.24.
Each month's total comprises the sum of three months' worth of ratings.

X0M1 Financial Forecast

X0M1 Earnings Forecast

Next quarter’s earnings estimate for X0M1 is €0.15 with a range of -€0.13 to €0.44. The previous quarter’s EPS was €0.15. X0M1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year X0M1 has Performed in-line its overall industry.
Next quarter’s earnings estimate for X0M1 is €0.15 with a range of -€0.13 to €0.44. The previous quarter’s EPS was €0.15. X0M1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year X0M1 has Performed in-line its overall industry.

X0M1 Sales Forecast

Next quarter’s sales forecast for X0M1 is €12.13M with a range of €10.21M to €14.06M. The previous quarter’s sales results were €10.74M. X0M1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year X0M1 has Performed in-line its overall industry.
Next quarter’s sales forecast for X0M1 is €12.13M with a range of €10.21M to €14.06M. The previous quarter’s sales results were €10.74M. X0M1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year X0M1 has Performed in-line its overall industry.

X0M1 Stock Forecast FAQ

What is DE:X0M1’s average 12-month price target, according to analysts?
Based on analyst ratings, XOMA Royalty Corporation’s 12-month average price target is 34.24.
    What is DE:X0M1’s upside potential, based on the analysts’ average price target?
    XOMA Royalty Corporation has 3.76% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is XOMA Royalty Corporation a Buy, Sell or Hold?
          XOMA Royalty Corporation has a consensus rating of Hold, which is based on 0 buy ratings, 3 hold ratings and 0 sell ratings.
            What is XOMA Royalty Corporation’s share price target?
            The average share price target for XOMA Royalty Corporation is 34.24. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €34.24 ,and the lowest forecast is €34.24. The average share price target represents 3.76% Increase from the current price of €33.
              What do analysts say about XOMA Royalty Corporation?
              XOMA Royalty Corporation’s analyst rating consensus is a Hold. This is based on the ratings of 3 Wall Streets Analysts.
                How can I buy shares of XOMA Royalty Corporation?
                To buy shares of DE:X0M1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.